Essex Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Essex Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-30,720	Closed	-$2.69M	–	456
2020 Q4	$2.69M	Buy	30,720 +15,038	+96%	+$1.32M	0.33%	97
2020 Q3	$1.19M	Sell	15,682 -29,530	-65%	-$2.25M	0.17%	188
2020 Q2	$5.58M	Buy	45,212 +6,893	+18%	+$850K	0.91%	17
2020 Q1	$3.24M	Buy	38,319 +492	+1%	+$41.6K	0.66%	32
2019 Q4	$3.2M	Buy	37,827 +30,074	+388%	+$2.54M	0.39%	69
2019 Q3	$523K	Buy	7,753 +1,119	+17%	+$75.5K	0.08%	287
2019 Q2	$568K	Sell	6,634 -7,281	-52%	-$623K	0.08%	294
2019 Q1	$1.24M	Sell	13,915 -61	-0.4%	-$5.42K	0.18%	181
2018 Q4	$1.19M	Sell	13,976 -6,863	-33%	-$584K	0.19%	167
2018 Q3	$2.02M	Buy	20,839 +8,406	+68%	+$815K	0.24%	132
2018 Q2	$1.17M	Sell	12,433 -210	-2%	-$19.8K	0.15%	206
2018 Q1	$1.03M	Buy	12,643 +859	+7%	+$69.6K	0.13%	205
2017 Q4	$1.05M	Buy	11,784 +2,663	+29%	+$238K	0.14%	210
2017 Q3	$849K	Buy	9,121 +1,618	+22%	+$151K	0.12%	222
2017 Q2	$681K	Sell	7,503 -23	-0.3%	-$2.09K	0.1%	234
2017 Q1	$661K	Sell	7,526 -949	-11%	-$83.4K	0.1%	238
2016 Q4	$702K	Sell	8,475 -992	-10%	-$82.2K	0.12%	211
2016 Q3	$876K	Sell	9,467 -5,944	-39%	-$550K	0.14%	185
2016 Q2	$1.2M	Buy	15,411 +90	+0.6%	+$7K	0.2%	118
2016 Q1	$1.26M	Sell	15,321 -203	-1%	-$16.7K	0.22%	103
2015 Q4	$1.63M	Sell	15,524 -33,126	-68%	-$3.47M	0.25%	94
2015 Q3	$5.12M	Buy	48,650 +18,675	+62%	+$1.97M	0.84%	34
2015 Q2	$4.1M	Sell	29,975 -15,188	-34%	-$2.08M	0.62%	42
2015 Q1	$5.63M	Buy	45,163 +6,095	+16%	+$760K	0.79%	40
2014 Q4	$3.53M	Sell	39,068 -17	-0%	-$1.54K	0.51%	54
2014 Q3	$2.82M	Buy	39,085 +7,788	+25%	+$562K	0.43%	66
2014 Q2	$1.95M	Sell	31,297 -2,158	-6%	-$134K	0.29%	112
2014 Q1	$2.28M	Sell	33,455 -1,417	-4%	-$96.7K	0.33%	97
2013 Q4	$2.45M	Buy	34,872 +5,105	+17%	+$359K	0.35%	80
2013 Q3	$2.15M	Buy	29,767 +15,278	+105%	+$1.1M	0.33%	88
2013 Q2	$808K	Buy	+14,489	New	+$808K	0.14%	174